As of 2026-03-19, the Relative Valuation of NGM Biopharmaceuticals Inc (NGM) is (14.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of NGM Biopharmaceuticals Inc based on Relative Valuation is -1072.1%.
The range of the Relative Valuation is (11.98) - (19.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 12.0x | 9.0x |
| Forward P/E multiples | 6.9x - 11.6x | 8.6x |
| Fair Price | (11.98) - (19.86) | (14.97) |
| Upside | -877.7% - -1389.4% | -1072.1% |
| Date | P/E |